Papers
8
Total Citations
63
H-Index
5
About
Yoji Nagashima is a leading urologic surgeon and researcher whose work centers on the surgical management of renal cell carcinoma (RCC) and other urologic malignancies, with a particular focus on robot-assisted laparoscopic and thoracoscopic techniques. His major contributions include pioneering investigations into the peritumoral pseudocapsule—a critical anatomical feature in partial nephrectomy—where he has characterized its pathological status and improved its preoperative detection using enhanced MDCT, directly informing surgical planning and outcomes. Nagashima has also advanced the treatment of advanced RCC, notably reporting on the novel combination of lenvatinib and pembrolizumab for cases with inferior vena cava tumor thrombus, a challenging clinical scenario. His work extends to rare thoracic tumors, such as mediastinal paraganglioma and pulmonary spindle cell carcinoma, demonstrating the versatility of robotic surgery. With papers cited up to 18 times, his research has shaped best practices in nephron-sparing surgery and multimodal therapy. Notable achievements include successful resections of complex, rib-invasive tumors and contributions to immunotherapy-radiotherapy combinations for metastatic bladder cancer, reflecting his commitment to pushing the boundaries of minimally invasive oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8